{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:10:28Z","timestamp":1769213428131,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.35","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T15:51:53Z","timestamp":1392911513000},"page":"e1063-e1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L)"],"prefix":"10.1038","volume":"5","author":[{"given":"K-j","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B R","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y C","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y H","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T K","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"BFcddis201435_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1176\/ajp.141.3.440","volume":"141","author":"GM Realmuto","year":"1984","unstructured":"Realmuto GM, Erickson WD, Yellin AM, Hopwood JH, Greenberg LM . Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. Am J Psychiatry 1984; 141: 440\u2013442.","journal-title":"Am J Psychiatry"},{"key":"BFcddis201435_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00607441","volume":"14","author":"R Ohman","year":"1978","unstructured":"Ohman R, Axelsson R . Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients. Eur J Clin Pharmacol 1978; 14: 111\u2013116.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFcddis201435_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0924-8579(00)00199-0","volume":"16","author":"MV Bettencourt","year":"2000","unstructured":"Bettencourt MV, Bosne-David S, Amaral L . Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents 2000; 16: 69\u201371.","journal-title":"Int J Antimicrob Agents"},{"key":"BFcddis201435_CR4","doi-asserted-by":"crossref","unstructured":"van Soolingen D, Hernandez-Pando R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L et al. The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. PLoS One 2010; 5.","DOI":"10.1371\/journal.pone.0012640"},{"key":"BFcddis201435_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","volume":"17","author":"S Kang","year":"2012","unstructured":"Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ et al. Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells. Apoptosis 2012; 17: 989\u2013997.","journal-title":"Apoptosis"},{"key":"BFcddis201435_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","volume":"120","author":"SB Rho","year":"2011","unstructured":"Rho SB, Kim BR, Kang S . A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)\/AKT pathway in ovarian cancer cells. Gynecol Oncol 2011; 120: 121\u2013127.","journal-title":"Gynecol Oncol"},{"key":"BFcddis201435_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel D, Spranger S, Vincendeau M, Grau M, Raffegerst S, Kloo B et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 2012; 22: 825\u2013837.","journal-title":"Cancer Cell"},{"key":"BFcddis201435_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:22:3:189","volume":"22","author":"I Gil-Ad","year":"2004","unstructured":"Gil-Ad I, Shtaif B, Levkovitz Y, Dayag M, Zeldich E, Weizman A . Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. J Mol Neurosci 2004; 22: 189\u2013198.","journal-title":"J Mol Neurosci"},{"key":"BFcddis201435_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","volume":"53","author":"Z Zhelev","year":"2004","unstructured":"Zhelev Z, Ohba H, Bakalova R, Hadjimitova V, Ishikawa M, Shinohara Y et al. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Cancer Chemother Pharmacol 2004; 53: 267\u2013275.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcddis201435_CR10","first-page":"107","volume":"15","author":"I Gil-Ad","year":"2006","unstructured":"Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I et al. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 2006; 15: 107\u2013112.","journal-title":"Oncol Rep"},{"key":"BFcddis201435_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/15563659509017984","volume":"33","author":"NA Buckley","year":"1995","unstructured":"Buckley NA, Whyte IM, Dawson AH . Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 1995; 33: 199\u2013204.","journal-title":"J Toxicol Clin Toxicol"},{"key":"BFcddis201435_CR12","first-page":"91","volume":"164","author":"S Dallaire","year":"2001","unstructured":"Dallaire S . Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval. CMAJ 2001; 164: 91\u201395.","journal-title":"CMAJ"},{"key":"BFcddis201435_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155\u2013162.","journal-title":"J Clin Invest"},{"key":"BFcddis201435_CR14","first-page":"553","volume":"60","author":"M Leverkus","year":"2000","unstructured":"Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 2000; 60: 553\u2013559.","journal-title":"Cancer Res"},{"key":"BFcddis201435_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673\u2013682.","journal-title":"Immunity"},{"key":"BFcddis201435_CR16","doi-asserted-by":"publisher","first-page":"35829","DOI":"10.1074\/jbc.M405538200","volume":"279","author":"Z Jin","year":"2004","unstructured":"Jin Z, McDonald ER 3rd, Dicker DT, El-Deiry WS . Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 2004; 279: 35829\u201335839.","journal-title":"J Biol Chem"},{"key":"BFcddis201435_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4161\/cbt.1.5.169","volume":"1","author":"MM Kelly","year":"2002","unstructured":"Kelly MM, Hoel BD, Voelkel-Johnson C . Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL-induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther 2002; 1: 520\u2013527.","journal-title":"Cancer Biol Ther"},{"key":"BFcddis201435_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/pros.10155","volume":"53","author":"CP Ng","year":"2002","unstructured":"Ng CP, Zisman A, Bonavida B . Synergy is achieved by complementation with Apo2L\/TRAIL and actinomycin D in Apo2L\/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Prostate 2002; 53: 286\u2013299.","journal-title":"Prostate"},{"key":"BFcddis201435_CR19","first-page":"3051","volume":"60","author":"H Walczak","year":"2000","unstructured":"Walczak H, Bouchon A, Stahl H, Krammer PH . Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res 2000; 60: 3051\u20133057.","journal-title":"Cancer Res"},{"key":"BFcddis201435_CR20","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1158\/1541-7786.MCR-08-0313","volume":"6","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Zhang B . TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res 2008; 6: 1861\u20131871.","journal-title":"Mol Cancer Res"},{"key":"BFcddis201435_CR21","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1038\/sj.onc.1204673","volume":"20","author":"T Fukazawa","year":"2001","unstructured":"Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T et al. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 2001; 20: 5225\u20135231.","journal-title":"Oncogene"},{"key":"BFcddis201435_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","volume":"121","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, Gao W, Du F, Wang X . Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121: 1085\u20131095.","journal-title":"Cell"},{"key":"BFcddis201435_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1357-2725(02)00390-4","volume":"35","author":"M Groll","year":"2003","unstructured":"Groll M, Huber R . Substrate access and processing by the 20S proteasome core particle. Int J Biochem Cell Biol 2003; 35: 606\u2013616.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcddis201435_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0028-3908(93)90096-L","volume":"32","author":"GS Dhaunsi","year":"1993","unstructured":"Dhaunsi GS, Singh B, Singh AK, Kirschner DA, Singh I . Thioridazine induces lipid peroxidation in myelin of rat brain. Neuropharmacology 1993; 32: 157\u2013167.","journal-title":"Neuropharmacology"},{"key":"BFcddis201435_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.bjp.0704672","volume":"136","author":"T Rodrigues","year":"2002","unstructured":"Rodrigues T, Santos AC, Pigoso AA, Mingatto FE, Uyemura SA, Curti C . Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis\u2014potentially implicated mechanisms. Br J Pharmacol 2002; 136: 136\u2013142.","journal-title":"Br J Pharmacol"},{"key":"BFcddis201435_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.leu.2402793","volume":"17","author":"R Bortul","year":"2003","unstructured":"Bortul R, Tazzari PL, Cappellini A, Tabellini G, Billi AM, Bareggi R et al. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. Leukemia 2003; 17: 379\u2013389.","journal-title":"Leukemia"},{"key":"BFcddis201435_CR27","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/sj.leu.2403044","volume":"17","author":"AM Martelli","year":"2003","unstructured":"Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L et al. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 2003; 17: 1794\u20131805.","journal-title":"Leukemia"},{"key":"BFcddis201435_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jpedsurg.2003.12.008","volume":"39","author":"S Kim","year":"2004","unstructured":"Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH . Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J Pediatr Surg 2004; 39: 516\u2013521.","journal-title":"J Pediatr Surg"},{"key":"BFcddis201435_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.surg.2005.05.012","volume":"138","author":"PG Rychahou","year":"2005","unstructured":"Rychahou PG, Murillo CA, Evers BM . Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL). Surgery 2005; 138: 391\u2013397.","journal-title":"Surgery"},{"key":"BFcddis201435_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3892\/ijo.2013.1789","volume":"42","author":"C Chen","year":"2013","unstructured":"Chen C, Chang YC, Lan MS, Breslin M . Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK\/ERK1\/2 and PI3K\/Akt signaling pathways. Int J Oncol 2013; 42: 1113\u20131119.","journal-title":"Int J Oncol"},{"key":"BFcddis201435_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2006.12.009","volume":"109","author":"H Moriyama","year":"2007","unstructured":"Moriyama H, Yonehara S . Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K\/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Immunol Lett 2007; 109: 36\u201346.","journal-title":"Immunol Lett"},{"key":"BFcddis201435_CR32","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/hep.21604","volume":"45","author":"A Moumen","year":"2007","unstructured":"Moumen A, Ieraci A, Patane S, Sole C, Comella JX, Dono R et al. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. Hepatology 2007; 45: 1210\u20131217.","journal-title":"Hepatology"},{"key":"BFcddis201435_CR33","doi-asserted-by":"publisher","first-page":"26915","DOI":"10.1074\/jbc.M313875200","volume":"279","author":"M Derouet","year":"2004","unstructured":"Derouet M, Thomas L, Cross A, Moots RJ, Edwards SW . Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem 2004; 279: 26915\u201326921.","journal-title":"J Biol Chem"},{"key":"BFcddis201435_CR34","doi-asserted-by":"publisher","first-page":"C255","DOI":"10.1152\/ajpcell.00618.2006","volume":"293","author":"JW Zmijewski","year":"2007","unstructured":"Zmijewski JW, Zhao X, Xu Z, Abraham E . Exposure to hydrogen peroxide diminishes NF-kappaB activation, IkappaB-alpha degradation, and proteasome activity in neutrophils. Am J Physiol Cell Physiol 2007; 293: C255\u2013C266.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFcddis201435_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/jcp.22414","volume":"226","author":"Y Ishihara","year":"2011","unstructured":"Ishihara Y, Takeuchi K, Ito F, Shimamoto N . Dual regulation of hepatocyte apoptosis by reactive oxygen species: increases in transcriptional expression and decreases in proteasomal degradation of BimEL. J Cell Physiol 2011; 226: 1007\u20131016.","journal-title":"J Cell Physiol"},{"key":"BFcddis201435_CR36","doi-asserted-by":"publisher","first-page":"C806","DOI":"10.1152\/ajpcell.00129.2003","volume":"285","author":"YP Li","year":"2003","unstructured":"Li YP, Chen Y, Li AS, Reid MB . Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285: C806\u2013C812.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFcddis201435_CR37","doi-asserted-by":"publisher","first-page":"23086","DOI":"10.1074\/jbc.272.37.23086","volume":"272","author":"F Shang","year":"1997","unstructured":"Shang F, Gong X, Taylor A . Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem 1997; 272: 23086\u201323093.","journal-title":"J Biol Chem"},{"key":"BFcddis201435_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1600-079X.2010.00793.x","volume":"49","author":"HJ Um","year":"2010","unstructured":"Um HJ, Kwon TK . Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells. J Pineal Res 2010; 49: 283\u2013290.","journal-title":"J Pineal Res"},{"key":"BFcddis201435_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jcb.21672","volume":"104","author":"S Kim","year":"2008","unstructured":"Kim S, Lee TJ, Leem J, Choi KS, Park JW, Kwon TK . Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J Cell Biochem 2008; 104: 895\u2013907.","journal-title":"J Cell Biochem"},{"key":"BFcddis201435_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/tx00026a012","volume":"5","author":"CP LeBel","year":"1992","unstructured":"LeBel CP, Ischiropoulos H, Bondy SC . Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 227\u2013231.","journal-title":"Chem Res Toxicol"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis201435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis201435","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:17:59Z","timestamp":1672960679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2]]}},"alternative-id":["BFcddis201435"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.35","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]},"assertion":[{"value":"18 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}